Advanced search
Publication Cover
Cancer Biology & Therapy Volume 20, 2019 - Issue 4
Submit an article Journal homepage
1,764
Views
22
CrossRef citations to date
0
Altmetric
Research Paper

Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies

Zhenlong YeShanghai Baize Medical Laboratory, Shanghai Engineering Research Center for Cell Therapy, Shanghai, ChinaCorrespondence[email protected]
View further author information
,
Yongmei DingDepartment of Biotherapy, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, ChinaView further author information
,
Zhuo ChenShanghai Baize Medical Laboratory, Shanghai Engineering Research Center for Cell Therapy, Shanghai, ChinaView further author information
,
Zhong LiShanghai Baize Medical Laboratory, Shanghai Engineering Research Center for Cell Therapy, Shanghai, ChinaView further author information
,
Shuo MaShanghai Baize Medical Laboratory, Shanghai Engineering Research Center for Cell Therapy, Shanghai, ChinaView further author information
,
Zenghui XuShanghai Baize Medical Laboratory, Shanghai Engineering Research Center for Cell Therapy, Shanghai, ChinaView further author information
,
Liang ChengShanghai Baize Medical Laboratory, Shanghai Engineering Research Center for Cell Therapy, Shanghai, China;Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USAView further author information
,
Xinyue WangShanghai Baize Medical Laboratory, Shanghai Engineering Research Center for Cell Therapy, Shanghai, ChinaView further author information
,
Xiaoxia ZhangShanghai Baize Medical Laboratory, Shanghai Engineering Research Center for Cell Therapy, Shanghai, ChinaView further author information
,
Na DingShanghai Baize Medical Laboratory, Shanghai Engineering Research Center for Cell Therapy, Shanghai, ChinaView further author information
,
Qian ZhangDepartment of Biotherapy, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Qijun QianShanghai Baize Medical Laboratory, Shanghai Engineering Research Center for Cell Therapy, Shanghai, China;Department of Biotherapy, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, ChinaView further author information
 show all
Pages 546-551 | Received 13 Jun 2018, Accepted 15 Oct 2018, Published online: 20 Dec 2018

References

  • Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781–791. PMID:15317891. doi:10.1056/NEJMoa040766
  • Zhang S, Li L, Wang T, Bian L, Hu H, Xu C, Liu B, Liu Y, Cristofanilli M, Jiang Z.. Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients. BMC Cancer 2016; 16:526.PMID:27456503, doi:10.1186/s12885-016-2578-5
  • Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008;8:329–340. PMID:18404148. doi:10.1038/nrc2375
  • Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC Jr. American Society of Clinical O. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287–5312. PMID:17954709. doi:10.1200/JCO.2007.14.2364
  • Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011;192:373–382. PMID:21300848. doi:10.1083/jcb.201010021
  • Li Y, Zhang X, Ge S, Gao J, Gong J, Lu M, Zhang Q, Cao Y, Wang DD, Lin PP, et al. Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer. Oncotarget. 2014;5:6594–6602. PMID:25026283. doi:10.18632/oncotarget.2175
  • Wu W, Zhang Z, Gao XH, Shen Z, Jing Y, Lu H, Li H, Yang X, Cui X, Li Y, et al. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH). Oncotarget 2017; 8:21639-49.PMID:28423493, doi:10.18632/oncotarget.15452
  • Hillig T, Horn P, Nygaard AB, Haugaard AS, Nejlund S, Brandslund I, Soletormos G. In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods. Tumour Biol. 2015;36:4597–4601. PMID:25608842. doi:10.1007/s13277-015-3105-z
  • Chen YY, Xu GB. Erratum to: effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer. Med Oncol. 2015;32:190. PMID:26021469. doi:10.1007/s12032-015-0629-4
  • Zhang Y, Wang F, Ning N, Chen Q, Yang Z, Guo Y, Xu D, Zhang D, Zhan T, Cui W. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer. Int J Cancer. 2015;136:1228–1233. PMID:25042121. doi:10.1002/ijc.29070
  • Coumans FA, Doggen CJ, Attard G, de Bono JS, Terstappen LW. All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer. Ann Oncol. 2010;21:1851–1857. PMID:20147742. doi:10.1093/annonc/mdq030
  • Bonnomet A, Syne L, Brysse A, Feyereisen E, Thompson EW, Noel A, Foidart JM, Birembaut P, Polette M, Gilles C. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene. 2012;31:3741–3753. PMID:22120722. doi:10.1038/onc.2011.540
  • Li Y, Gong J, Zhang Q, Lu Z, Gao J, Li Y, Cao Y, Shen L. Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer. Br J Cancer. 2016;114:138–145. PMID:26784122. doi:10.1038/bjc.2015.417
  • Aceto N, Toner M, Maheswaran S, Haber DA. En route to metastasis: circulating tumor cell clusters and epithelial-to-mesenchymal transition. Trends Cancer. 2015;1:44–52. PMID:28741562. doi:10.1016/j.trecan.2015.07.006
  • Gosens MJ, van Kempen LC, van de Velde CJ, van Krieken JH, Nagtegaal ID. Loss of membranous Ep-CAM in budding colorectal carcinoma cells. Mod Pathol. 2007;20:221–232. PMID:17361206. doi:10.1038/modpathol.3800733
  • Driemel C, Kremling H, Schumacher S, Will D, Wolters J, Lindenlauf N, Mack B, Baldus SA, Hoya V, Pietsch JM, et al. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer. Oncogene. 2014;33:4904–4915. PMID:24141784. doi:10.1038/onc.2013.441
  • Zhang L, Ridgway LD, Wetzel MD, Ngo J, Yin W, Kumar D, Goodman JC, Groves MD, Marchetti D. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med. 2013;5:180ra48. PMID:23576814. doi:10.1126/scitranslmed.3005109
  • Zhang L, Ridgway LD, Wetzel MD, Ngo J, Yin W, Kumar D, Goodman JC, Groves MD, Marchetti D. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med. 2013;5:180ra48. PMID:23576814. doi:10.1126/scitranslmed.3005109

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.